FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.706
-0.067 (-8.61%)
At close: Feb 21, 2025, 4:00 PM
0.658
-0.048 (-6.80%)
After-hours: Feb 21, 2025, 7:59 PM EST
FibroGen Revenue
FibroGen had revenue of $46.33M in the quarter ending September 30, 2024, with 15.45% growth. This brings the company's revenue in the last twelve months to $180.02M, up 16.15% year-over-year. In the year 2023, FibroGen had annual revenue of $147.75M with 4.99% growth.
Revenue (ttm)
$180.02M
Revenue Growth
+16.15%
P/S Ratio
0.39
Revenue / Employee
$370,401
Employees
486
Market Cap
71.13M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 147.75M | 7.02M | 4.99% |
Dec 31, 2022 | 140.73M | -94.58M | -40.19% |
Dec 31, 2021 | 235.31M | 58.99M | 33.46% |
Dec 31, 2020 | 176.32M | -80.26M | -31.28% |
Dec 31, 2019 | 256.58M | 43.62M | 20.48% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
FGEN News
- 2 days ago - Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million - Benzinga
- 2 days ago - FibroGen sells China unit to AstraZeneca in deal worth $160 million - Reuters
- 2 days ago - FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million - GlobeNewsWire
- 2 months ago - FibroGen Appoints David DeLucia as Chief Financial Officer - GlobeNewsWire
- 3 months ago - FibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 3 months ago - FibroGen Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - FibroGen to Report Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha